In contrast, distribution of vimentin is abundant in tumor (upper left) than normal region (lower right) (Figure 5(e)) and elevated in poorly differentiated (right) than well-differentiated tumor (left) (Figure 5(f)), suggesting induction of vimentin according to the aggressiveness of the BRCA1-associated lacrimal gland tumor (Figures 5(e) and 5(f)). The gene discussed is BRCA1; the disease is neoplasm.